Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Mar 27, 2023; 15(3): 430-439
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.430
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.430
Table 1 The baseline characteristic analysis of the patients
Variables | Non-EIPL group, n = 75 | EIPL group, n = 75 | P value |
Age in yr | 66.93 ± 9.38 | 64.55 ± 8.22 | 0.099 |
Sex | 0.200 | ||
Male | 51 | 58 | |
Female | 24 | 17 | |
BMI in kg/m2 | 21.51 ± 2.29 | 21.64 ± 3.34 | 0.786 |
Smoking status | 0.373 | ||
Yes | 55 | 50 | |
No | 20 | 25 | |
Tumor location | 0.260 | ||
Upper | 21 | 14 | |
Middle | 11 | 17 | |
Low | 43 | 44 | |
Differentiated grade | 0.121 | ||
High | 0 | 0 | |
Middle | 55 | 45 | |
Low | 20 | 30 | |
T stage | 0.405 | ||
T3 | 4 | 2 | |
T4 | 71 | 73 | |
N stage | 0.112 | ||
N0 | 13 | 24 | |
N1 | 18 | 12 | |
N2 | 14 | 17 | |
N3 | 30 | 22 | |
Tumor size in cm | 5.52 ± 2.21 | 5.37 ± 2.32 | 0.671 |
Borrmann classification | 0.100 | ||
II | 7 | 14 | |
III | 68 | 61 | |
CEA in g/L | 16.21 ± 78.06 | 14.13 ± 35.88 | 0.834 |
Neutrophil count as 109/L | 3.49 ± 1.32 | 4.71 ± 8.39 | 0.215 |
Lymphocyte count as 109/L | 1.35 ± 0.47 | 1.76 ± 2.48 | 0.164 |
NLR | 3.02 ± 1.96 | 3.03 ± 2.20 | 0.989 |
Platelet as 109/L | 202.52 ± 61.39 | 226.19 ± 90.94 | 0.064 |
Table 2 Outcomes after surgery
Variables | Non-EIPL group, n = 75 | EIPL group, n = 75 | P value |
Type of surgery | 0.242 | ||
Total | 55 | 61 | |
Distal | 20 | 14 | |
Time, surgery to first flatus in d | 4.19 ± 0.99 | 3.95 ± 0.87 | 0.108 |
Postoperative hospital stay in d | 15.26 ± 3.10 | 14.48 ± 1.97 | 0.072 |
Abdominal pain | 10/75 | 5/75 | 0.174 |
Ileus | 15/75 | 3/75 | 0.003 |
Abdominal abscess | 9/75 | 1/75 | 0.009 |
Leakage | 5/75 | 2/75 | 0.246 |
Bleeding | 6/75 | 3/75 | 0.302 |
Neutrophil count as 109/L | 10.36 ± 3.32 | 10.03 ± 3.56 | 0.552 |
Lymphocyte cell as 109/L | 1.02 ± 0.63 | 1.00 ± 0.60 | 0.817 |
NLR | 13.48 ± 8.55 | 11.87 ± 5.22 | 0.169 |
Platelet as 109/L | 171.00 ± 59.98 | 179.73 ± 60.38 | 0.381 |
Table 3 Univariate analysis of overall survival
Variable | β | HR (95%CI) | P value |
Sex | 0.514 | 1.671 (0.983-2.841) | 0.058 |
Age | 0.024 | 1.025 (0.994-1.056) | 0.114 |
EIPL/Non-EIPL | -0.991 | 0.371 (0.218,0.631) | 0.000 |
Tumor size | 0.192 | 1.211 (1.088-1.348) | 0.000 |
Type of surgery | 0.185 | 1.203 (0.653-2.214) | 0.553 |
Tumor location | 0.075 | 0.928 (0.689-1.250) | 0.622 |
Borrmann classification | -1.474 | 0.229 (0.072-0.731) | 0.013 |
Differentiated grade | 0.491 | 0.612 (0.351-1.067) | 0.083 |
T stage | 1.250 | 3.489 (1.094-11.130) | 0.035 |
N stage | 0.535 | 1.707 (1.339-2.176) | 0.000 |
Vascular invasion | -0.954 | 0.385 (0.235-0.632) | 0.000 |
Table 4 Multivariate analysis of overall survival
Variable | β | HR (95%CI) | P value |
EIPL/Non-EIPL | -0.861 | 0.423 (0.246-0.727) | 0.002 |
Tumor size | 0.139 | 1.149 (1.025-1.289) | 0.017 |
Borrmann classification | -0.268 | 0.765 (0.211-2.775) | 0.684 |
T stage | 1.395 | 4.034 (1.255-12.971) | 0.019 |
N stage | 0.313 | 1.368 (1.034-1.811) | 0.029 |
Vascular invasion | -0.608 | 0.545 (0.317-0.935) | 0.027 |
- Citation: Song ED, Xia HB, Zhang LX, Ma J, Luo PQ, Yang LZ, Xiang BH, Zhou BC, Chen L, Sheng H, Fang Y, Han WX, Wei ZJ, Xu AM. Efficacy and outcome of extensive intraoperative peritoneal lavage plus surgery vs surgery alone with advanced gastric cancer patients. World J Gastrointest Surg 2023; 15(3): 430-439
- URL: https://www.wjgnet.com/1948-9366/full/v15/i3/430.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i3.430